Ignite Creation Date:
2025-12-24 @ 3:40 PM
Ignite Modification Date:
2026-04-28 @ 2:11 PM
Study NCT ID:
NCT04781192
Status:
RECRUITING
Last Update Posted:
2024-02-23
First Post:
2021-02-25
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
The Purpose of This Trial is to Determine if Regorafenib Plus Durvalumab (MEDI4736) is Safe and Effective in Treatment of Chemo Refractory Advanced Biliary Tract Cancers
Sponsor:
University of Kansas Medical Center
Organization: